SINEMET TABS 25/250mg (Carbidopa/Levodopa)

Description

SINEMET 25/250mg Tablets is a globally recognized brand manufactured by Organon (formerly under MSD/Merck), containing a fixed combination of Carbidopa 25mg and Levodopa 250mg, indicated for the treatment of Parkinson’s disease and parkinsonism syndrome. Levodopa converts into dopamine in the brain to help improve the signs of Parkinson’s disease, while Carbidopa — an aromatic amino acid decarboxylase inhibitor — helps levodopa work more effectively by slowing the speed at which levodopa is broken down in the body. SINEMET is particularly useful in relieving symptoms of parkinsonism including rigidity, bradykinesia, tremor, dysphagia, and postural instability, and is especially effective in patients where the therapeutic response to levodopa alone is irregular or uneven throughout the day.